{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:06:01Z","timestamp":1761156361277,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":89,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493972333"},{"type":"electronic","value":"9781493972340"}],"license":[{"start":{"date-parts":[[2017,9,10]],"date-time":"2017-09-10T00:00:00Z","timestamp":1505001600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-7234-0_13","type":"book-chapter","created":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T16:55:23Z","timestamp":1505148923000},"page":"155-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The N-butyl-N-4-hydroxybutyl Nitrosamine Mouse Urinary Bladder Cancer Model"],"prefix":"10.1007","author":[{"given":"Paula A.","family":"Oliveira","sequence":"first","affiliation":[]},{"given":"C\u00e1rmen","family":"Vasconcelos-N\u00f3brega","sequence":"additional","affiliation":[]},{"given":"Rui M.","family":"Gil da Costa","sequence":"additional","affiliation":[]},{"given":"Regina","family":"Arantes-Rodrigues","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,9,10]]},"reference":[{"issue":"1","key":"13_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62(1):10\u201329","journal-title":"CA Cancer J Clin"},{"key":"13_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/03008880802285032","volume":"218","author":"DM Parkin","year":"2008","unstructured":"Parkin DM (2008) The global burden of urinary bladder cancer. Scand J Urol Nephrol Suppl 218:12\u201320","journal-title":"Scand J Urol Nephrol Suppl"},{"issue":"1","key":"13_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejcsup.2016.01.001","volume":"14","author":"J Bellmunt","year":"2016","unstructured":"Bellmunt J, Mottet N, De Santis M (2016) Urothelial carcinoma management in elderly or unfit patients. EJC Suppl 14(1):1\u201320","journal-title":"EJC Suppl"},{"issue":"1","key":"13_CR4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","volume":"71","author":"S Antoni","year":"2016","unstructured":"Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F (2016) Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 71(1):96\u2013108. doi: 10.1016\/j.eururo.2016.06.010","journal-title":"Eur Urol"},{"issue":"1","key":"13_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.7314\/APJCP.2016.17.1.381","volume":"17","author":"N Mahdavifar","year":"2016","unstructured":"Mahdavifar N, Ghoncheh M, Pakzad R, Momenimovahed Z, Salehiniya H (2016) Epidemiology, incidence and mortality of bladder cancer and their relationship with the development index in the world. Asian Pac J Cancer Prev 17(1):381\u2013386","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"13_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.urolonc.2011.10.010","volume":"30","author":"KJ Kiriluk","year":"2012","unstructured":"Kiriluk KJ, Prasad SM, Patel AR, Steinberg GD, Smith ND (2012) Bladder cancer risk from occupational and environmental exposures. Urol Oncol 30(2):199\u2013211","journal-title":"Urol Oncol"},{"key":"13_CR7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7555\/JBR.27.20130026","volume":"27","author":"H Chu","year":"2013","unstructured":"Chu H, Wang M, Zhang Z (2013) Bladder cancer epidemiology and genetic susceptibility. J Biomed Res 27:170\u2013178","journal-title":"J Biomed Res"},{"key":"13_CR8","first-page":"15","volume":"1","author":"J Santos","year":"2012","unstructured":"Santos J, Chaves J, Videira M, Botelho M, Costa J, Oliveira J, Santos L (2012) Schistosomiasis haematobium and bladder cancer: retrospective analysis of 145 patients admitted to the urology. Department at the Am\u00e9rico Boavida Hospital, Luanda. Acta Urol 1:15\u201320","journal-title":"Acta Urol"},{"key":"13_CR9","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1100\/2011\/251920","volume":"11","author":"KA Kader","year":"2011","unstructured":"Kader KA (2011) Bladder cancer. Sci World J 11:2565\u20132566","journal-title":"Sci World J"},{"issue":"5","key":"13_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1517\/17460441.2014.902930","volume":"9","author":"PA Oliveira","year":"2014","unstructured":"Oliveira PA, Arantes-Rodrigues R, Vasconcelos-N\u00f3brega C (2014) Animal models of urinary bladder cancer and their application to novel drug discovery. Expert Opin Drug Discov 9(5):485\u2013503","journal-title":"Expert Opin Drug Discov"},{"issue":"10061","key":"13_CR11","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmstr\u00f6m PU, Choi W, Guo CC, Lotan Y, Kassouf W (2016) Bladder cancer. Lancet 388(10061):2796\u20132810. doi: 10.1016\/S0140-6736(16)30512-8","journal-title":"Lancet"},{"issue":"6Suppl4","key":"13_CR12","first-page":"S193","volume":"3","author":"V Chalasani","year":"2009","unstructured":"Chalasani V, Chin JL, Izawa JI (2009) Histologic variants of urothelial bladder cancer and non urothelial histology in bladder cancer. Can Urol Assoc J 3(6Suppl4):S193\u2013S198","journal-title":"Can Urol Assoc J"},{"issue":"7","key":"13_CR13","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/j.1365-2559.2008.03167.x","volume":"54","author":"JH Shanks","year":"2009","unstructured":"Shanks JH, Iczkowski KA (2009) Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics. Histopathology 54(7):885\u2013900","journal-title":"Histopathology"},{"issue":"1","key":"13_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/1756287211431976","volume":"4","author":"A Anastasiadis","year":"2012","unstructured":"Anastasiadis A, de Reijke TM (2012) Best practice in the treatment of nonmuscle invasive bladder cancer. Ther Adv Urol 4(1):13\u201332","journal-title":"Ther Adv Urol"},{"issue":"1","key":"13_CR15","first-page":"31","volume":"10","author":"E Pasin","year":"2008","unstructured":"Pasin E, Josephson DY, Mitra AP, Cote RJ, Stein JP (2008) Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history. Rev Urol 10(1):31\u201343","journal-title":"Rev Urol"},{"key":"13_CR16","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1038\/modpathol.2008.235","volume":"22","author":"DJ Grignon","year":"2009","unstructured":"Grignon DJ (2009) The current classification of urothelial neoplasms. Mod Pathol 22:S60\u2013S69","journal-title":"Mod Pathol"},{"issue":"11","key":"13_CR17","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1158\/1078-0432.CCR-09-3013","volume":"16","author":"TC Zuiverloon","year":"2010","unstructured":"Zuiverloon TC, van der Aa MN, van der Kwast TH, Steyerberg EW, Lingsma HF, Bangma CH, Zwarthoff EC (2010) Fibroblast growth factor receptor 3 mutation analysis on voided urine for surveillance of patients with low-grade non-muscle-invasive bladder cancer. Clin Cancer Res 16(11):3011\u20133018","journal-title":"Clin Cancer Res"},{"key":"13_CR18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00345-007-0213-4","volume":"25","author":"MA Knowles","year":"2007","unstructured":"Knowles MA (2007) Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target. World J Urol 25:581\u2013593","journal-title":"World J Urol"},{"issue":"1","key":"13_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.purol.2012.09.015","volume":"23","author":"N No\u00ebl","year":"2013","unstructured":"No\u00ebl N, Couteau J, Maillet G, Gobet F, d'Aloisio F, Minier C, Pfister C (2013) Preliminary study of p53 and FGFR3 gene mutations in the urine for bladder tumors. Prog Urol 23(1):29\u201335","journal-title":"Prog Urol"},{"issue":"2","key":"13_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/path.1202","volume":"198","author":"BW Rhijn Van","year":"2002","unstructured":"Van Rhijn BW, Montironi R, Zwarthoff EC, J\u00f6bsis AC, van der Kwast TH (2002) Frequent FGFR3 mutations in urothelial papilloma. J Pathol 198(2):245\u2013251","journal-title":"J Pathol"},{"key":"13_CR21","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1038\/sj.bjc.6602251","volume":"91","author":"AA Memon","year":"2004","unstructured":"Memon AA, Sorensen BS, Melgard P, Fokdal L, Thykjaer T, Nexo E (2004) Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients. Br J Cancer 91:2034\u20132041","journal-title":"Br J Cancer"},{"issue":"2","key":"13_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3233\/BLC-150016","volume":"1","author":"J Jarow","year":"2015","unstructured":"Jarow J, Maher VE, Tang S, Ibrahim A, Kim G, Sridhara R, Pazdur R (2015) Development of systemic and topical drugs to treat non-muscle invasive bladder cancer. Bl Cancer 1(2):133\u2013136","journal-title":"Bl Cancer"},{"issue":"1","key":"13_CR23","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.eururo.2011.10.029","volume":"62","author":"J Palou","year":"2012","unstructured":"Palou J, Sylvester RJ, Faba OR, Parada R, Pena JA, Algaba F, Villavicencio H (2012) Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guerin. Eur Urol 62(1):118\u2013125","journal-title":"Eur Urol"},{"issue":"3","key":"13_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0959-8049(99)00262-2","volume":"36","author":"X Garcia del Muro","year":"2000","unstructured":"Garcia del Muro X, Torregrosa A, Mu\u00f1oz J, Castellsagu\u00e9 X, Condom E, Vigu\u00e9s F, Arance A, Fabra A, Germ\u00e0 JR (2000) Prognostic value of the expression of E-cadherin and beta-catenin in bladder cancer. Eur J Cancer 36(3):357\u2013362","journal-title":"Eur J Cancer"},{"issue":"9","key":"13_CR25","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nrc1697","volume":"5","author":"XR Wu","year":"2005","unstructured":"Wu XR (2005) Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 5(9):713\u2013725","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"13_CR26","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1200\/JCO.2004.03.118","volume":"22","author":"SF Shariat","year":"2004","unstructured":"Shariat SF, Tokunaga H, Zhou J, Kim J, Ayala GE, Benedict WF, Lerner SP (2004) p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer. J Clin Oncol 22(6):1014\u20131024","journal-title":"J Clin Oncol"},{"issue":"7","key":"13_CR27","first-page":"1217","volume":"57","author":"C Cordon-Cardo","year":"1997","unstructured":"Cordon-Cardo C, Zhang ZF, Dalbagni G, Drobnjak M, Charytonowicz E, Hu SX, Xu HJ, Reuter VE, Benedict WF (1997) Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors. Cancer Res 57(7):1217\u20131221","journal-title":"Cancer Res"},{"key":"13_CR28","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.eursup.2009.06.009","volume":"Suppl 8","author":"MR Braasch","year":"2009","unstructured":"Braasch MR, Bohle A, O\u2019Donnell MA (2009) Intravesical instillation treatment of non\u2013muscle-invasive bladder cancer. Eur Urol Suppl 8:549\u2013555","journal-title":"Eur Urol"},{"key":"13_CR29","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1101\/gad.1789109","volume":"23","author":"JE Rosenberg","year":"2009","unstructured":"Rosenberg JE, Hahn WC (2009) Bladder cancer: modeling and translation. Genes Dev 23:655\u2013659","journal-title":"Genes Dev"},{"issue":"1","key":"13_CR30","first-page":"1","volume":"19","author":"D Zips","year":"2005","unstructured":"Zips D, Thames HD, Baumann M (2005) New anticancer agents: in vitro and in vivo evaluation. In Vivo 19(1):1\u20137","journal-title":"In Vivo"},{"key":"13_CR31","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/nrd2075","volume":"5","author":"D Dam Van","year":"2006","unstructured":"Van Dam D, De Deyn PP (2006) Drug discovery in dementia: the role of rodent models. Nat Rev Drug Discov 5:956\u2013970","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"13_CR32","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/17460441.2016.1174690","volume":"11","author":"PA Oliveira","year":"2016","unstructured":"Oliveira PA, Gil da Costa RM, Vasconcelos-N\u00f3brega C, Arantes-Rodrigues R, Pinto-Leite R (2016) Challenges with in vitro and in vivo experimental models of urinary bladder cancer for novel drug discovery. Expert Opin Drug Discov 11(6):599\u2013607","journal-title":"Expert Opin Drug Discov"},{"key":"13_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.toxicon.2011.08.016","volume":"58","author":"RM Gil da Costa","year":"2011","unstructured":"Gil da Costa RM, Oliveira PA, Vilanova M, Bastos MM, Lopes CC, Lopes C (2011) Ptaquiloside-induced B-cell lymphoproliferative and early-stage urothelial lesions in mice. Toxicon 58:543\u2013549","journal-title":"Toxicon"},{"key":"13_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jhazmat.2011.12.046","volume":"203-204","author":"RM Gil da Costa","year":"2012","unstructured":"Gil da Costa RM, Bastos MMSM, Oliveira PA, Lopes C (2012) Bracken-associated human and animal health hazards: chemical, biological and pathological evidence. J Hazard Mater 203-204:1\u201312","journal-title":"J Hazard Mater"},{"key":"13_CR35","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/tox.21803","volume":"29","author":"RM Gil da Costa","year":"2014","unstructured":"Gil da Costa RM, Oliveira PA, Bastos MMSM, Lopes CC, Lopes C (2014) Ptaquiloside-induced early-stage urothelial lesions: increased cell proliferation and intact \u03b2-catenin and E-cadherin expression. Environ Toxicol 29:763\u2013769","journal-title":"Environ Toxicol"},{"issue":"1","key":"13_CR36","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/ilar\/ilu018","volume":"55","author":"DW Knapp","year":"2014","unstructured":"Knapp DW, Ramos-Vara JA, Moore GE et al (2014) Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development. ILAR J 55(1):100\u2013118","journal-title":"ILAR J"},{"issue":"1","key":"13_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S1357-4310(96)20031-0","volume":"3","author":"DW Knapp","year":"1997","unstructured":"Knapp DW, Waters DJ (1997) Naturally occurring cancer in pet dogs: important models for developing improved cancer therapy for humans. Mol Med Today 3(1):8\u201311","journal-title":"Mol Med Today"},{"issue":"1","key":"13_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ilar\/ilu022","volume":"55","author":"MD Lairmore","year":"2014","unstructured":"Lairmore MD, Khanna C (2014) Naturally occurring diseases in animals: contributions to translational medicine. ILAR J 55(1):1\u20133","journal-title":"ILAR J"},{"issue":"3","key":"13_CR39","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00345-009-0381-5","volume":"27","author":"HC Arentsen","year":"2009","unstructured":"Arentsen HC, Hendricksen K, Oosterwijk E, Witjes JA (2009) Experimental rat bladder urothelial cell carcinoma models. World J Urol 27(3):313\u2013317","journal-title":"World J Urol"},{"issue":"3","key":"13_CR40","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3892\/etm.2014.1837","volume":"8","author":"J Ding","year":"2014","unstructured":"Ding J, Xu D, Pan C, Ye M, Kang J, Bai Q, Qi J (2014) Current animal models of bladder cancer: awareness of translatability (review). Exp Ther Med 8(3):691\u2013699","journal-title":"Exp Ther Med"},{"issue":"4","key":"13_CR41","first-page":"1273","volume":"33","author":"R Arantes-Rodrigues","year":"2013","unstructured":"Arantes-Rodrigues R, Cola\u00e7o A, Pinto-Leite R, Oliveira PA (2013) In vitro and in vivo experimental models as tools to investigate the efficacy of antineoplastic drugs on urinary bladder cancer. Anticancer Res 33(4):1273\u20131296","journal-title":"Anticancer Res"},{"key":"13_CR42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1023\/A:1006196614142","volume":"17","author":"MP Rosenbert","year":"1998","unstructured":"Rosenbert MP, Bortner D (1998) Why transgenic and knockout animal models should be used (for drug efficacy studies in cancer). Cancer Metastasis Rev 17:295\u2013299","journal-title":"Cancer Metastasis Rev"},{"key":"13_CR43","first-page":"2035","volume":"46","author":"PJ Russell","year":"1986","unstructured":"Russell PJ, Raghavan D, Gregory P et al (1986) Bladder cancer xenografts: a model of tumor cell heterogeneity. Cancer Res 46:2035\u20132040","journal-title":"Cancer Res"},{"key":"13_CR44","first-page":"2834","volume":"59","author":"JH G\u00fcnther","year":"1999","unstructured":"G\u00fcnther JH, Jurczok A, Wulf T et al (1999) Optimizing syngeneic orthotopic murine bladder cancer (MB49). Cancer Res 59:2834\u20132837","journal-title":"Cancer Res"},{"issue":"6","key":"13_CR45","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1016\/j.juro.2009.08.020","volume":"183","author":"ESY Chan","year":"2009","unstructured":"Chan ESY, Patel AR, Smith AK et al (2009) Optimizing orthotopic bladder tumor implantation in a syngeneic mouse model. J Urol 183(6):2926\u20132931","journal-title":"J Urol"},{"key":"13_CR46","first-page":"2","volume":"28","author":"PA Oliveira","year":"2006","unstructured":"Oliveira PA, Cola\u00e7o A, De la Cruz Palomino LF, Lopes C (2006) Experimental bladder carcinogenesis\u2013rodent models. Exp Oncol 28:2\u201311","journal-title":"Exp Oncol"},{"issue":"5","key":"13_CR47","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/iep.12145","volume":"96","author":"RM Gil da Costa","year":"2015","unstructured":"Gil da Costa RM, Oliveira PA, Vasconcelos-N\u00f3brega C, Arantes-Rodrigues R, Pinto-Leite R, Cola\u00e7o A, de la Cruz PLF, Lopes C (2015) Altered expression of CKs 14\/20 is an early event in a rat model of multistep bladder carcinogenesis. Int J Exp Pathol 96(5):319\u2013325. doi: 10.1111\/iep.12145","journal-title":"Int J Exp Pathol"},{"key":"13_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1289\/ehp.835051","volume":"50","author":"SM Cohen","year":"1983","unstructured":"Cohen SM (1983) Promotion in urinary bladder carcinogenesis. Environ Health Perspect 50:51\u201359","journal-title":"Environ Health Perspect"},{"key":"13_CR49","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/(SICI)1098-2388(199709\/10)13:5<291::AID-SSU2>3.0.CO;2-8","volume":"13","author":"SL Johansson","year":"1997","unstructured":"Johansson SL, Cohen SM (1997) Epidemiology and etiology of bladder cancer. Semin Surg Oncol 13:291\u2013298","journal-title":"Semin Surg Oncol"},{"issue":"4","key":"13_CR50","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3123\/jemsge.30.132","volume":"30","author":"SM Cohen","year":"2008","unstructured":"Cohen SM (2008) Tresholds in genotoxicity and carcinogenicity: urinary bladder carcinogenesis. Genes Environ 30(4):132\u2013138","journal-title":"Genes Environ"},{"key":"13_CR51","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.3892\/mmr.2016.4762","volume":"13","author":"T Jiang","year":"2016","unstructured":"Jiang T, Lui T, Li L, Yang Z, Bai Y, Liu D, Kong C (2016) Knockout of phospholipase C\u03b5 attenuates N-butyl-N-(4-hydroxybutyl) nitrosamine-induced bladder tumorigenesis. Mol Med Rep 13:2039\u20132045","journal-title":"Mol Med Rep"},{"key":"13_CR52","first-page":"3666","volume":"48","author":"M Bonfanti","year":"1988","unstructured":"Bonfanti M, Magagnotti C, Bonati M, Fanelli R, Airoldi L (1988) Pharmacokinetic profile and metabolism of N-nitrosobutyl-(4-hydroxybutyl)amine in rats. Cancer Res 48:3666\u20133669","journal-title":"Cancer Res"},{"key":"13_CR53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0304-3835(95)03786-V","volume":"93","author":"SS Mirvish","year":"1995","unstructured":"Mirvish SS (1995) Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett 93:17\u201348","journal-title":"Cancer Lett"},{"issue":"11","key":"13_CR54","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1093\/carcin\/bgm146","volume":"28","author":"K Iida","year":"2007","unstructured":"Iida K, Itoh K, Maher JM, Kumagai Y, Oyasu R, Mori Y, Shimazui T, Akaza H, Yamamoto M (2007) Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis. Carcinogenesis 28(11):2398\u20132403","journal-title":"Carcinogenesis"},{"issue":"6","key":"13_CR55","first-page":"856","volume":"71","author":"E Suzuki","year":"1980","unstructured":"Suzuki E, Okada M (1980) Metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine in the rat. Gann 71(6):856\u2013862","journal-title":"Gann"},{"issue":"10-11","key":"13_CR56","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1248\/yakushi1947.117.10-11_884","volume":"117","author":"M Mochizuki","year":"1997","unstructured":"Mochizuki M, Suzuki E, Okada M (1997) Structure and metabolic fate of N-nitrosodialkylamines in relation to their organotropic carcinogenicity with special reference to induction of urinary bladder tumors. Yakugaku Zasshi 117(10-11):884\u2013894","journal-title":"Yakugaku Zasshi"},{"key":"13_CR57","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/019262339802600114","volume":"26","author":"SM Cohen","year":"1998","unstructured":"Cohen SM (1998) Urinary bladder carcinogenesis. Toxicol Pathol 26:121\u2013127","journal-title":"Toxicol Pathol"},{"issue":"3","key":"13_CR58","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/01926230701197115","volume":"35","author":"SM Cohen","year":"2007","unstructured":"Cohen SM, Ohnishi T, Clark NM, He J, Arnold LL (2007) Investigations of rodent urinary bladder carcinogens: collection, processing, and evaluation of urine and bladders. Toxicol Pathol 35(3):337\u2013347","journal-title":"Toxicol Pathol"},{"key":"13_CR59","first-page":"825","volume":"67","author":"M Okada","year":"1976","unstructured":"Okada M, Suzuki E, Hashimoto Y (1976) Carcinogenicity of N-nitrosamines related to N-butyl-N-(4-Hydroxybutyl)nitrosamine and N, N-Dibutylnitrosamine in ACI\/N rats. Gann 67:825\u2013834","journal-title":"Gann"},{"key":"13_CR60","first-page":"3697","volume":"47","author":"L Airoldi","year":"1987","unstructured":"Airoldi L, Magagnotti C, Bonfanti M, Fanelli R (1987) Development of an experimental model for studying bladder carcinogen metabolism using the isolated rat urinary bladder. Cancer Res 47:3697\u20133700","journal-title":"Cancer Res"},{"key":"13_CR61","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/(SICI)1097-0215(19991126)83:5<700::AID-IJC22>3.0.CO;2-Q","volume":"83","author":"K Yamamoto","year":"1999","unstructured":"Yamamoto K, Nakata D, Tada M, Tonoki H, Nishida T, Hirai A, Ba Y, Aoyama T, Hamada J, Furuuchi K, Harada H, Hirai K, Shibahara N, Katsuoka Y, Moriuchi T (1999) A functional and quantitative mutational analysis of p53 mutations in yeast indicates strand biases and different roles of mutations in DMBA- and BBN-induced tumors in rats. Int J Cancer 83:700\u2013705","journal-title":"Int J Cancer"},{"key":"13_CR62","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/toxsci\/57.1.4","volume":"57","author":"JH Weisburger","year":"2000","unstructured":"Weisburger JH, Williams GM (2000) The distinction between genotoxic and epigenetic carcinogens and implication for cancer risk. Toxicol Sci 57:4\u20135","journal-title":"Toxicol Sci"},{"key":"13_CR63","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/1097-0142(19840301)53:5<1093::AID-CNCR2820530513>3.0.CO;2-8","volume":"53","author":"JR Drago","year":"2004","unstructured":"Drago JR (2004) The noble rat bladder cancer model\u2013FANFT induced Tumours. Cancer 53:1093\u20131099","journal-title":"Cancer"},{"issue":"9","key":"13_CR64","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1093\/carcin\/13.9.1651","volume":"13","author":"AM Mann","year":"1992","unstructured":"Mann AM, Asamoto M, Chlapowski FJ, Masui T, Macatee TL, Cohen SM (1992) Ras involvement in cells transformed with 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT) in vitro and with N-[4-(5-nitro-2-furyl)-2-thiazoyl]formamide in vivo. Carcinogenesis 13(9):1651\u20131655","journal-title":"Carcinogenesis"},{"key":"13_CR65","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00345-009-0374-4","volume":"27","author":"LO Reis","year":"2009","unstructured":"Reis LO, Pereira TC, Favaro WJ, Cagnon VH, Lopes-Cendes I, Ferreira U (2009) Experimental animal model and RNA interference: a promising association for bladder cancer research. World J Urol 27:353","journal-title":"World J Urol"},{"issue":"1","key":"13_CR66","first-page":"F145","volume":"254","author":"LA Spry","year":"1988","unstructured":"Spry LA, Rubinstein J, Rettke C, Zenser TV, Davis BB (1988) Renal metabolic\/excretory coupling. Am J Physiol 254(1):F145\u2013F152","journal-title":"Am J Physiol"},{"key":"13_CR67","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/bjc.1982.60","volume":"45","author":"NJ Severs","year":"1982","unstructured":"Severs NJ, Barnes SH, Wright R, Hicks RM (1982) Induction of bladder cancer in rats by fractionated intravesicular doses of N-methyl-N-nitrosourea. Br J Cancer 45:337\u2013351","journal-title":"Br J Cancer"},{"issue":"20","key":"13_CR68","first-page":"6668","volume":"50","author":"GD Steinberg","year":"1990","unstructured":"Steinberg GD, Brendler CB, Ichikawa T, Squire RA, Isaacs JT (1990) Characterization of an N-methyl-N-nitrosourea-induced autochthonous rat bladder cancer model. Cancer Res 50(20):6668\u20136674","journal-title":"Cancer Res"},{"issue":"4","key":"13_CR69","first-page":"727","volume":"26","author":"C Vasconcelos-N\u00f3brega","year":"2012","unstructured":"Vasconcelos-N\u00f3brega C, Cola\u00e7o A, Lopes C, Oliveira PA (2012) Review: BBN as an urothelial carcinogen. In Vivo 26(4):727\u2013739","journal-title":"In Vivo"},{"key":"13_CR70","first-page":"439","volume-title":"The mouse in biomedical research","author":"SM Cohen","year":"1982","unstructured":"Cohen SM, Friedell GH (1982) Neoplasms of the urinary system. In: The mouse in biomedical research. Academic Press, New York, pp 439\u2013463"},{"key":"13_CR71","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF00390992","volume":"108","author":"N Ito","year":"1984","unstructured":"Ito N, Shirai T, Fukushima S, Hirose M (1984) Dose-response study of urinary bladder carcinogenesis in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine. J Cancer Res Clin Oncol 108:169\u2013173","journal-title":"J Cancer Res Clin Oncol"},{"key":"13_CR72","first-page":"2011","volume":"46","author":"M Ohtani","year":"1986","unstructured":"Ohtani M, Kakizoe T, Nishio Y, Sato S, Sugimura T, Fukushima S, Niijima T (1986) Sequential changes of mouse bladder epithelium during induction of invasive carcinomas by N-butyl-N-(4-hydroxybutyl)nitrosamine. Cancer Res 46:2011\u20132004","journal-title":"Cancer Res"},{"key":"13_CR73","first-page":"101","volume":"7","author":"H Wanibuchi","year":"2006","unstructured":"Wanibuchi H, Wei M, Salim EI, Kinoshita A, Morimura K, Sudo K, Fukushima S (2006) Inhibition of rat urinary bladder carcinogenesis by the antiangiogenic drug TNP-470. Asian Pac J Cancer Prev 7:101\u2013107","journal-title":"Asian Pac J Cancer Prev"},{"key":"13_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159102","volume":"11","author":"SC Wang","year":"2016","unstructured":"Wang SC, Huang CC, Shen CH, Lin LC, Zhao PW, Chen SY, Deng YC, Liu YW (2016) Gene expression and DNA methylationstatus of glutathione-S-transferase Mu1 and Mu5 in urothelial carcinoma. PLoS One 11:e0159102","journal-title":"PLoS One"},{"key":"13_CR75","first-page":"207","volume":"24","author":"PA Oliveira","year":"2005","unstructured":"Oliveira PA, Palmeira C, Louren\u00e7o L, Lopes C (2005) Evaluation of DNA content in preneoplastic changes of mouse urinary bladder induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. J Exp Clin Cancer Res 24:207\u2013214","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"13_CR76","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/laban0512-129","volume":"41","author":"R Arantes-Rodrigues","year":"2012","unstructured":"Arantes-Rodrigues R, Henriques A, Pinto-Leite R, Faustino-Rocha A, Pinho-Oliveira J, Teixeira-Guedes C, Seixas F, Gama A, Cola\u00e7o B, Cola\u00e7o A, Oliveira PA (2012) The effects of repeated oral gavage on the health of male CD-1 mice. Lab Anim (NY) 41(5):129\u2013134","journal-title":"Lab Anim (NY)"},{"issue":"1","key":"13_CR77","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3109\/00498257709036241","volume":"7","author":"M Okada","year":"1977","unstructured":"Okada M, Ishidate M (1977) Metabolic fate of N-butyl-N-(4-hydroxybutyl)-nitrosamine and its analogues: selective induction of urinary bladder tumours in the rat. Xenobiotica 7(1):11\u201324","journal-title":"Xenobiotica"},{"key":"13_CR78","first-page":"69","volume":"65","author":"Y Hashimoto","year":"1974","unstructured":"Hashimoto Y, Suzuki K, Okada M (1974) Induction of urinary bladder tumors by intravesicular instillation of butyl(4-hydroxybutyl)nitrosoamine and its principal urinary metabolite, butyl(3-carboxypropyl)nitrosoamine in rats. Gann 65:69\u201373","journal-title":"Gann"},{"key":"13_CR79","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/bjc.1977.95","volume":"35","author":"K Fuji","year":"1977","unstructured":"Fuji K, Odashima S, Okada M (1977) Induction of tumours by administration of N-dibutylnitrosamine and derivatives to infant mice. Br J Cancer 35:610\u2013614","journal-title":"Br J Cancer"},{"key":"13_CR80","first-page":"781","volume":"68","author":"H Tsuda","year":"1977","unstructured":"Tsuda H, Miyata Y, Hagiwara A, Hasegawa R, Shirai T, Ito N (1977) Damage and repair of DNA in urinary bladder epithelium of rats treated with N-butyl-N-(4-hydroxybutyl) nitrosamine. Gann 68:781\u2013783","journal-title":"Gann"},{"issue":"1","key":"13_CR81","first-page":"5","volume":"36","author":"PA Oliveira","year":"2009","unstructured":"Oliveira PA, Pires MJ, N\u00f3brega C, Arantes-Rodrigues R, Calado AM, Carrola J, Ginja M, Cola\u00e7o A (2009) Technical report: technique of bladder catheterization in female mice and rats for intravesical instillation in models of bladder cancer. Scand J Lab Anim Sci 36(1):5\u20139","journal-title":"Scand J Lab Anim Sci"},{"key":"13_CR82","doi-asserted-by":"crossref","first-page":"34112","DOI":"10.18632\/oncotarget.8746","volume":"7","author":"J Xu","year":"2016","unstructured":"Xu J, Wang Y, Hua X, Xu J, Tian Z, Jin H, Li J, Wu XR, Huang C (2016) Inhibition of PHLPP2\/cyclin D1 protein translation contributes to the tumor suppressive effect of NF\u03baB2 (p100). Oncotarget 7:34112\u201334130","journal-title":"Oncotarget"},{"key":"13_CR83","first-page":"60","volume":"74","author":"E Suzuki","year":"1983","unstructured":"Suzuki E, Anjo T, Aoki J, Okada M (1983) Species variations in the metabolism of N-butyl-N-(4-hydroxybutyl)nitrosamine and related compounds in relation to urinary bladder carcinogenesis. Gann 74:60\u201368","journal-title":"Gann"},{"key":"13_CR84","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/ncb2956","volume":"16","author":"K Shin","year":"2014","unstructured":"Shin K, Lim A, Odegaard JI, Honeycutt JD, Kawano S, Hsieh MH, Beachy PA (2014) Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma. Nat Cell Biol 16:469\u2013478","journal-title":"Nat Cell Biol"},{"key":"13_CR85","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0168-1591(01)00200-3","volume":"76","author":"PLP Loo Van","year":"2002","unstructured":"Van Loo PLP, Kruitwagenb CLJJ, Koolhaasc JM, Van de Weerdd HA, Van Zutphena LFM, Baumansa V (2002) Influence of cage enrichment on aggressive behaviour and physiological parameters in male mice. Appl Anim Behav Sci 76:65\u201381","journal-title":"Appl Anim Behav Sci"},{"key":"13_CR86","doi-asserted-by":"crossref","DOI":"10.1201\/b12900","volume-title":"The laboratory mouse","author":"PJ Danneman","year":"2012","unstructured":"Danneman PJ, Suckow MA, Brayton CF (2012) The laboratory mouse, 2nd edn. Taylor and Francis, London","edition":"2"},{"key":"13_CR87","volume-title":"Animal models for the study of human disease","author":"PM Conn","year":"2013","unstructured":"Conn PM (2013) Animal models for the study of human disease, 1st edn. Elsevier, Amsterdam","edition":"1"},{"key":"13_CR88","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/432821a","volume":"432","author":"DP Wolfer","year":"2004","unstructured":"Wolfer DP, Litvin O, Morf S, Nitsch RM, Lipp HP, W\u00fcrbel H (2004) Laboratory animal welfare: cage enrichment and mouse behaviour. Nature 432:821\u2013822","journal-title":"Nature"},{"key":"13_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066401","volume":"8","author":"K Gouveia","year":"2013","unstructured":"Gouveia K, Hurst JL (2013) Reducing mouse anxiety during handling: effect of experience with handling tunnels. PLoS One 8:e66401","journal-title":"PLoS One"}],"container-title":["Methods in Molecular Biology","Urothelial Carcinoma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7234-0_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T16:41:50Z","timestamp":1692981710000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7234-0_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,10]]},"ISBN":["9781493972333","9781493972340"],"references-count":89,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7234-0_13","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2017,9,10]]},"assertion":[{"value":"10 September 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}